Azidus   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Chennai India (1984)

Organization Overview

First Clinical Trial
2006
NCT01229085
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Azidus Brasil | Azidus Brasil Pesquisa Científica e Desenvolvimento Ltda | Azidus Brasil Pesquisa Científica e LTDA | Azidus Brasil Scientific Research and Development Ltda | Azidus Brazil | Azidus Laboratories Ltd.

Active Ingredients

Drugs in Phase 3 Trials (51)

acetylsalicylic acid (aspirin) (1 trial)

beclomethasone (vanceril) (1 trial)

bismuth sodium tartrate (1 trial)

bovine heparin (2 trials)

camphor (1 trial)

cellavita (2 trials)

chondroitin (2 trials)

citric acid (1 trial)

clemastine (TAVIST) (2 trials)

clobetasol (dermovate) (1 trial)

collagenase clostridium histolyticum (xiaflex) (1 trial)

doxylamine (1 trial)

enoxaparin (lovenox) (3 trials)

epoetin (Epogen) (6 trials)

ethinyl estradiol (Estinyl) (1 trial)

eukalyptol (1 trial)

fexofenadine (allegra) (1 trial)

gentamicin (garamycin) (1 trial)

ginseng (2 trials)

glucosamine (2 trials)

guaifenesin (2 trials)

halobetasol (ultravate) (1 trial)

heparin (liquaemin) (16 trials)

hydrochloride etafedrine (1 trial)

hydroquinone (1 trial)

immunoglobulin anti-rhd (1 trial)

loratadine (claritin) (2 trials)

menthol (Salonpas) (2 trials)

methylcatechol (1 trial)

mometasone (elocon) (2 trials)

multivitamins (2 trials)

neomycin (2 trials)

nitazoxanide (alinia) (4 trials)

norgestrel (Ovral) (1 trial)

pancrelipase (creon) (2 trials)

polymyxin b sulfate (poly-rx) (1 trial)

porcine heparin (2 trials)

prednisone (meticorten) (1 trial)

procaine merethoxylline (1 trial)

pseudoephedrine (Benylin) (2 trials)

rimabotulinumtoxinB (Myobloc) (1 trial)

salicylic acid (2 trials)

sodium bicarbonate (1 trial)

sominex (1 trial)

testosterone (delatestryl) (1 trial)

tobramycin (nebcin) (1 trial)

tretinoin (Retin-A) (1 trial)

triamcinolone (kenalog) (1 trial)

triluma (1 trial)

urea (4 trials)

venoruton (1 trial)

Drugs in Phase 2 Trials (5)

bnt162b2 (1 trial)

cnm-znag (1 trial)

covishield (1 trial)

MCTI-CIMATEC-HDT RNA (1 trial)

methotrexate (1 trial)

Drugs in Phase 1 Trials (15)

atorvastatin (lipitor) (1 trial)

azithromycin (zithromax) (2 trials)

bz371a (1 trial)

dexibuprofen (2 trials)

dienogest (natazia) (1 trial)

estradiol (progynon depot) (1 trial)

hydrochlorothiazide (esidrix) (1 trial)

hydroxychloroquine (plaquenil) (2 trials)

interferon beta-1b (betaseron) (1 trial)

leuprolide (lupron) (1 trial)

losartan (cozaar) (1 trial)

nestacell (1 trial)

octreotide (sandostatin) (1 trial)

sargramostim (leukine) (1 trial)

somatropin (protropin) (1 trial)

Drugs in Other Trials (1)

interferon alpha-2a (roferon-a) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acromegaly (Phase 1)

Anemia (Phase 3)

Burns (Phase 3)

Cataract (Phase 3)

Communicable Diseases (Phase 3)

Conjunctivitis (Phase 3)

Conjunctivitis, Bacterial (Phase 3)

Cough (Phase 3)

Dermatitis (Phase 3)

Exocrine Pancreatic Insufficiency (Phase 3)

Fatigue (Phase 3)

Fetomaternal Transfusion (Phase 3)

Folliculitis (Phase 3)

Headache (Phase 3)

Hemorrhage (Phase 3)

Huntington Disease (Phase 3)

Hypogonadism (Phase 3)

Infections (Phase 3)

Inflammation (Phase 3)

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 3)

Melanosis (Phase 3)

Osteoarthritis (Phase 3)

Pneumonia (Phase 1)

Psoriasis (Phase 3)

Renal Insufficiency (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Perennial (Phase 3)

Signs and Symptoms (Phase 3)

Skin Ulcer (Phase 3)

Sleep Initiation and Maintenance Disorders (Phase 3)

Tension-Type Headache (Phase 3)

Thromboembolism (Phase 3)

Thrombosis (Phase 3)

Ulcer (Phase 3)

Venous Insufficiency (Phase 3)

Venous Thromboembolism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 79
  • # of Trial APIs: 72